LEADER 01533nam  2200349z- 450 
001 9910694144503321
005 20061115084227.0
035   $a(CKB)5860000000030222
035   $a(BIP)013859529
035   $a(EXLCZ)995860000000030222
100   $a20220406c2006uuuu  -u-         -
101 0 $aeng
200 10$aOversight and administration of the 340B drug discount program $eimproving efficiency and transparency : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, December 15, 2005
215   $a1 online resource (iii, 73 p.) $cill
311   $a0-16-077318-0 
517   $aOversight and administration of the 340B drug discount program 
606   $aPrescription pricing$xGovernment policy$zUnited States
606   $aPoor$xPharmaceutical assistance$zUnited States
606   $aOlder people$xPharmaceutical assistance$zUnited States
610   $aPoor
610   $aOlder people
610   $aDrugs
610   $aSocial science
610   $aMedical
615  0$aPrescription pricing$xGovernment policy
615  0$aPoor$xPharmaceutical assistance
615  0$aOlder people$xPharmaceutical assistance
712 02$aUnited States, Congress House Committee on Energy and Commerce Subcommittee on Oversight and Investigations Staff,$4oth
906   $aBOOK
912   $a9910694144503321
996   $aOversight and administration of the 340B drug discount program$93156123
997   $aUNINA